this predetermined that all concrete dose products, except effervescent tablets and powders would have to be packaged into the child resistant packaging. for packing these products, there are two basic formats nonreclosable blisterstrip packs and reclosable plastic or glass potsbottles. bsi had introduced a standard test was whereby the reclosable containers&rsquo child resistance could be examined. this resulted into the introduction of a variety of packaging solutions, the most common being the &ldquoline up the arrows&rdquo and &ldquocliklok&rdquo type of cap. no such standard could be agreed upon for strip blister packs. the differences in the opinions being due to the type of the packaging and the truth that they were &ldquounit dose&rdquo, they were naturally child resistant. along with this, it was argued that there were too many variables in the content and makeup of the pack in order to make it a feasible proposition. e.g. variation in blister packing machines, variation in heat seal adhesives, thickness of the foil, size and shape of the pack, size and shape of the dose etc. as a result, instead of launching a regular test for nonreclosable packs, the wording was altered to &ldquostrip and blister packs must be formulated of materials such as to make them kid resistant&rdquo. this obviously meant that the two different formats were not contending on a plane playing field, a point made constantly and raucously by the container producers ever since. in the summer of 2000, the situation changed, when a 3year old kid took out 44 iron tablets that were packed in pvcfoil blisters, gulped down them and unfortunately died as a result. a working party on child resistance of europe, uk was a member of which, had been moving ahead gradually towards approving a set for nonreclosable packs, when this misfortune occurred. furthermore, the uk also decided that enough was enough and declared that it was going to push ahead with an independent child resistant examination for nonreclosable packs. this it did, and on 21st december 2001, bs 84042001was introduced. now this has been swapped with the latest european standard en14375. the outcome of this standard is the existing legislation on paracetamol and aspirin now can be enacted for both kinds of packaging. i.e now a level playing field is in place and organizations offering these products in nonreclosable packs can no more claim that their packaging is child resistant without demonstrating it. gp solutions is a packaging solutions company which works independent, with access to patents and products suitable for use within the healthcare and pharmaceutical sector. dose guard&trade is approved and gp solution patented technology. dose guard merges child resistance with better senior friendly access for nonreclosable wallets and blister packs. dose guard&trade, which works as a selfadhesive barrier, is suitable for application straightforwardly on to the packaging formats mentioned below. 1. all forms of thermo and cold formed blister packs. 2. clinical & commercial wallets in most blister packs, a merger of multipart adhesive as well as die cutting technology offers better child resistance without the need for validation, stability study analysis, and retooling. every blister packaging line will need a machine for labeling placed between the die stations and sealing or at the out feed prior to cartonner checkweigher. source of information httpwww.gppackaging.comcrp.htm
